Abstract
In mammalian sex determination, the Y-linked gene Sry acts within the early gonad as a switch to trigger high expression of Sox9 in cells of the supporting cell lineage. SOX9 then acts on many target genes required for Sertoli cell differentiation and function. These include signalling molecules such as AMH, which eliminates the anlagen of the female reproductive tract in male embryos, as well as other molecules that direct the differentiation of other cell types along the male pathway, including steroidogenic cell precursors, which differentiate into Leydig cells. The latter synthesise testosterone (T), which masculinises the rest of the embryo either directly or after to conversion to dihydrotestosterone (DHT) or estrogen (E) at sites of action, including the brain. Until fairly recently many believed that all differences in the brain and behaviour were due to the activity of T or high levels of E during late fetal or early postnatal development. However, there are many genes on the X and a few on the Y chromosome that could exert direct effects, either independently of steroid hormone action or in conjunction with it. Indeed recent work has suggested that this is indeed the case. Sry itself is expressed in the brain, as are other Y-linked genes. And despite the process of X chromosome inactivation, which equalises X-linked gene dosage between males and females, many X-linked genes can have an effect either because they escape inactivation or because they are subject to parental genomic imprinting (where alleles behave differently according to whether they are maternally or paternally inherited). I will review the current status of research in this area as well as describe our own contribution.